Compare Revvity Inc (RVTY) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs TORM plc — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while TORM plc trades at $29.05 (market cap $2.93B). The key difference: Revvity Inc is far larger — about 4.4× TORM plc's market cap, and TORM plc pays the higher dividend (9.77%). Which is the better fit depends on your goals.
| RVTY | TRMD | |
|---|---|---|
Market Cap | $12.91B | $2.93B |
Sector | Technology | Technology |
52-Week High | $117.75 | $34.87 |
52-Week Low | $82.26 | $18.77 |
Enterprise Value | $15.23B | $3.82B |
Dividend Yield | 0.24% | 9.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
TRMD trades at $28.97, down 0.75% today, with technical indicators showing bearish momentum despite oversold RSI conditions. The company maintains strong fundamentals with a P/E of 8.4, net margin of 24.41%, and robust cash flow generation. Recent Q1 2026 earnings missed expectations but management raised full-year guidance, supported by strong tanker market conditions and a $0.70 dividend declaration.
The stock presents a compelling value opportunity with attractive valuation metrics and 100% analyst buy ratings. Key risks include earnings volatility from freight rate fluctuations and negative net cash flow trends. Upside catalysts include potential merger discussions with Hafnia and sustained strong tanker market fundamentals through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
